**Health**
## Major Study Concludes MenB Vaccine Offers No Protection Against Gonorrhoea
**A significant new study has definitively concluded that the Meningitis B (MenB) vaccine provides no protective immunity against gonorrhoea infections. This finding challenges a previously held belief and the practice of offering the vaccine to at-risk men with the hope of preventing the sexually transmitted infection (STI).**
The research, conducted by a team of scientists, clarifies the efficacy of the MenB vaccine, stating unequivocally that it does not confer cross-protection against *Neisseria gonorrhoeae*, the bacterium responsible for gonorrhoea.
The premise for potentially using the MenB vaccine against gonorrhoea stemmed from the genetic similarities between *Neisseria meningitidis*, the cause of Meningitis B, and *Neisseria gonorrhoeae*. Some earlier observations and limited studies had suggested a possible, albeit modest, protective effect, leading to discussions and, in some contexts, the recommendation of the MenB vaccine for individuals at high risk of gonorrhoea infection.
However, this comprehensive study has now provided robust evidence to counter that assumption. The findings underscore the specific role of the MenB vaccine, whose primary and proven purpose remains the prevention of Meningitis B, a serious bacterial infection that can lead to meningitis and sepsis.
For the prevention of gonorrhoea and other sexually transmitted infections, the advice from public health officials and healthcare providers remains unchanged and critically important:
* **Consistent and Correct Condom Use:** Barrier methods, such as condoms, are highly effective in preventing the transmission of gonorrhoea and a wide range of other STIs.
* **Regular STI Screening:** Sexually active individuals, particularly those with multiple partners or new partners, should undergo regular screening for gonorrhoea and other STIs. Early detection and treatment are crucial to prevent complications and further transmission.
This study serves as an important clarification for both healthcare practitioners and the public, reinforcing that evidence-based practices are paramount in managing and preventing infectious diseases. While vaccine research continues to explore new avenues, established preventative measures remain the cornerstone of protection against gonorrhoea.
